Pathology & Oncology Research

, Volume 18, Issue 2, pp 421–427 | Cite as

Cosmetic Outcome 1–5 Years After Breast Conservative Surgery, Irradiation and Systemic Therapy

  • Gyöngyi Kelemen
  • Zoltán Varga
  • György Lázár
  • László Thurzó
  • Zsuzsanna Kahán
Research
First Online:
Received:
Accepted:

Abstract

The late side-effects of the local therapy of early breast cancer depend on many patient- and therapy-related parameters. We aimed at investigating the factors that influence the cosmetic and functional outcomes among our breast cancer patients after breast-conserving surgery and conformal radiotherapy, with or without adjuvant systemic therapy. A study was made of the association of the cosmetic outcome after a median follow-up time of 2.4 years and the clinical data on 198 patients extracted from a prospectively compiled database. Breast tenderness occurred more frequently among patients ≤50 years old (p < 0.05). Long-term side effects were related to radiotherapy-related factors the most, while no effect of the systemic therapy could be detected. The risk of hyperpigmentation, breast edema and breast fibrosis increased by 18%, 23% and 7%, respectively for every 100 cm3 increase in the irradiated breast volume, while that of breast edema and breast fibrosis increased by 21% and 12%, respectively for every 10 cm3 increase in the boost volume. Patients who received a photon boost were significantly more likely to develop breast edema and fibrosis than those who received electrons (p < 0.005). Dose inhomogeneity was related to the volume of the irradiated breast (p = 0.037). Dyspigmentation developed more often among patients older than 50 years, while smoking favoured both dyspigmentation and teleangiectasia. Breast edema was related to dyspigmentation (p = 0.003), fibrosis (p < 0.001) and breast asymmetry (p = 0.032), whereas none of these abnormalities were associated with teleangiectasia. Body image changes were more frequent at a younger age (p < 0.005), while the need to change clothing habits occurred more often at an older age (p < 0.05). Radiotherapy-related parameters appear to exert the greatest effect on the overall cosmetic outcome after breast-conserving surgery and postoperative radiotherapy.

Keywords

Breast-conserving therapy Cosmesis Fibrosis Radiotherapy dose Irradiated volume 
This is a preview of subscription content, log in to check access.

Notes

Conflict of Interest Statement

None declared.

References

  1. 1.
    Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M et al (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19:1688–1697PubMedGoogle Scholar
  2. 2.
    Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRefGoogle Scholar
  3. 3.
    Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232PubMedCrossRefGoogle Scholar
  4. 4.
    Offersen BV, Overgaard M, Kroman N, Overgaard J (2009) Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol 90:1–13PubMedCrossRefGoogle Scholar
  5. 5.
    Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, Pintilie M et al (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351:963–970PubMedCrossRefGoogle Scholar
  6. 6.
    Fowble B, Fein DA, Hanlon AL, Eisenberg BL, Hoffman JP, Sigurdson ER et al (1996) The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. Int J Radiat Oncol Biol Phys 35:669–677PubMedCrossRefGoogle Scholar
  7. 7.
    Munshi A, Kakkar S, Bhutani R, Jalali R, Budrukkar A, Dinshaw KA (2009) Factors influencing cosmetic outcome in breast conservation. Clin Oncol (R Coll Radiol) 21:285–293CrossRefGoogle Scholar
  8. 8.
    Azria D, Gourgou S, Sozzi WJ, Zouhair A, Mirimanoff RO, Kramar A et al (2004) Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer 91:1251–1260PubMedCrossRefGoogle Scholar
  9. 9.
    Azria D, Betz M, Bourgier C, Sozzi WJ, Ozsahin M (2010) Identifying patients at risk for late radiation-induced toxicity. Crit Rev Oncol Hematol, Epub ahead of printGoogle Scholar
  10. 10.
    Azria D, Belkacemi Y, Romieu G, Gourgou S, Gutowski M, Zaman K et al (2010) Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol 11:258–265PubMedCrossRefGoogle Scholar
  11. 11.
    Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25:3259–3265PubMedCrossRefGoogle Scholar
  12. 12.
    Wazer DE, Morr J, Erban JK, Schmid CH, Ruthazer R, Schmidt-Ullrich RK (1997) The effects of postradiation treatment with tamoxifen on local control and cosmetic outcome in the conservatively treated breast. Cancer 80:732–740PubMedCrossRefGoogle Scholar
  13. 13.
    Collette S, Collette L, Budiharto T, Horiot JC, Poortmans PM, Struikmans H et al (2008) Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 ‘boost versus no boost’. Eur J Cancer 44:2587–2599PubMedCrossRefGoogle Scholar
  14. 14.
    Taylor ME, Perez CA, Halverson KJ, Kuske RR, Philpott GW, Garcia DM et al (1995) Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 31:753–764PubMedCrossRefGoogle Scholar
  15. 15.
    Johansen J, Overgaard J, Rose C, Engelholm SA, Gadeberg CC, Kjaer M et al (2002) Cosmetic outcome and breast morbidity in breast-conserving treatment—results from the Danish DBCG-82TM national randomized trial in breast cancer. Acta Oncol 41:369–380PubMedCrossRefGoogle Scholar
  16. 16.
    Curran D, van Dongen JP, Aaronson NK, Kiebert G, Fentiman IS, Mignolet F et al (1998) Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG). Eur J Cancer 34:307–314PubMedCrossRefGoogle Scholar
  17. 17.
    Cardoso MJ, Cardoso J, Santos AC, Vrieling C, Christie D, Liljegren G et al (2007) Factors determining esthetic outcome after breast cancer conservative treatment. Breast J 13:140–146PubMedCrossRefGoogle Scholar
  18. 18.
    Johansen J, Overgaard J, Overgaard M (2007) Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation. Acta Oncol 46:525–533PubMedCrossRefGoogle Scholar
  19. 19.
    Kahan Z, Csenki M, Varga Z, Szil E, Cserhati A, Balogh A et al (2007) The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 68:673–681PubMedCrossRefGoogle Scholar
  20. 20.
    Van Limbergen E, Rijnders A, van der Schueren E, Lerut T, Christiaens R (1989) Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol 16:253–267PubMedCrossRefGoogle Scholar
  21. 21.
    Borger JH, Kemperman H, Smitt HS, Hart A, van Dongen J, Lebesque J et al (1994) Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 30:1073–1081PubMedGoogle Scholar
  22. 22.
    Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ et al (1992) Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 10:356–363PubMedGoogle Scholar
  23. 23.
    Pezner RD, Patterson MP, Hill LR, Vora NL, Desai KR, Lipsett JA (1985) Breast retraction assessment. Multiple variable analysis of factors responsible for cosmetic retraction in patients treated conservatively for stage I or II breast carcinoma. Acta Radiol Oncol 24:327–330PubMedCrossRefGoogle Scholar
  24. 24.
    Lilla C, Ambrosone CB, Kropp S, Helmbold I, Schmezer P, von Fournier D et al (2007) Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat 106:143–150PubMedCrossRefGoogle Scholar
  25. 25.
    Porta EA (2002) Pigments in aging: an overview. Ann N Y Acad Sci 959:57–65PubMedCrossRefGoogle Scholar
  26. 26.
    Moody AM, Mayles WP, Bliss JM, A’Hern RP, Owen JR, Regan J et al (1994) The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol 33:106–112PubMedCrossRefGoogle Scholar
  27. 27.
    Murphy C, Anderson PR, Li T, Bleicher RJ, Sigurdson ER, Goldstein LJ et al (2010) Impact of the radiation boost on outcomes after breast-conserving surgery and radiation. Int J Radiat Oncol Biol Phys Epub ahead of printGoogle Scholar
  28. 28.
    Ellenbogen R, Jankauskas S, Collini FJ (1990) Achieving standardized photographs in aesthetic surgery. Plast Reconstr Surg 86:955–961PubMedCrossRefGoogle Scholar
  29. 29.
    Sarin R, Dinshaw KA, Shrivastava SK, Sharma V, Deore SM (1993) Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer. Int J Radiat Oncol Biol Phys 27:285–292PubMedGoogle Scholar
  30. 30.
    Hill-Kayser CE, Chacko D, Hwang WT, Vapiwala N, Solin LJ (2010) Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost. Int J Radiat Oncol Biol Phys, Epub ahead of printGoogle Scholar
  31. 31.
    Harsolia A, Kestin L, Grills I, Wallace M, Jolly S, Jones C et al (2007) Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 68:1375–1380PubMedCrossRefGoogle Scholar
  32. 32.
    McDonald MW, Godette KD, Whitaker DJ, Davis LW, Johnstone PA (2010) Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost. Int J Radiat Oncol Biol Phys 77:523–530PubMedCrossRefGoogle Scholar
  33. 33.
    Abner AL, Recht A, Vicini FA, Silver B, Hayes D, Come S et al (1991) Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 21:331–338PubMedCrossRefGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2011

Authors and Affiliations

  • Gyöngyi Kelemen
    • 1
  • Zoltán Varga
    • 1
  • György Lázár
    • 2
  • László Thurzó
    • 1
  • Zsuzsanna Kahán
    • 1
  1. 1.Department of OncotherapyUniversity of SzegedSzegedHungary
  2. 2.Department of SurgeryUniversity of SzegedSzegedHungary

Personalised recommendations